Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | COVID-19 | Research

Acute and persistent symptoms of COVID-19 infection in school-aged children: a retrospective study from China

Authors: Honglin Wang, Fangfang Lu, Xiuxian Ni, Rijing Luo, Linxiang Chen, Jing Yuan, Zhen Zhang, Qiuying Lv

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

The long-term sequelae of Coronavirus disease 2019 (COVID-19) in children are unclear. We investigated COVID-19 symptoms in school-aged children to determine their impact on patients and their families.

Methods

This cross-sectional study, conducted on February 25–28, 2023, selected a representative kindergarten and 9-year school from Shenzhen, China. There were randomly two classes each for the 12 grades from kindergarten to junior high school. The school-aged children were aged 3–16 years. Literate parents completed an online questionnaire related to their children’s COVID-19 symptoms since December 1, 2022. Descriptive statistics were computed as necessary. Univariate and multivariable linear regression analyses were performed, and variables with a p-value < 0.05 were considered to have a significant association with the subjective feeling scores for COVID-19 infection.

Results

We included 936 school-aged children, with a COVID-19 infection rate of 68.5%. The prevalence of LC 28 (illness with symptoms lasting for 28 days) was 3.4%. During acute infection, the median number of the 641 children’s symptoms was 3.0 (IQR: 1.0–5.0) and the median score of subjective feelings was 15.0 (IQR: 11.0–24.5). The top three symptoms were fever, cough/expectoration, and rhinobyon. Age of 13–16 years (adjusted beta: 3.60, 95% CI: 0.32–6.88) and comorbidities (adjusted beta: 3.47, 95% CI: 1.20–5.73) were independently associated with higher subjective feelings (p < 0.05). The top three characteristics associated with LC 28 were alopecia (33.3%, 5/15), cognitive dysfunction (29.2%, 7/24), and emotional problem (28.6%, 6/21).

Conclusions

Children with COVID-19 have a short duration of symptoms and milder symptoms, so they can self-medicate to minimize hospital crowding. Children with basic diseases require prompt attention. Although LC 28 is uncommon in children, mental and psychological problems after COVID-19 recovery should not be ignored.
Literature
1.
go back to reference World Health Organization. Listings of WHO’s response to COVID-19. Available at: Accessed on: 11 February 2022. World Health Organization. Listings of WHO’s response to COVID-19. Available at: Accessed on: 11 February 2022.
3.
go back to reference Asakawa T. Focusing on development of novel sampling approaches and alternative therapies for COVID-19: are they still useful in an era after the pandemic? Biosci Trends. 2022;16(6):386–8.CrossRefPubMed Asakawa T. Focusing on development of novel sampling approaches and alternative therapies for COVID-19: are they still useful in an era after the pandemic? Biosci Trends. 2022;16(6):386–8.CrossRefPubMed
5.
go back to reference COVID-19 rapid. Guideline: managing the long-term effects of COVID-19 (NG188. Evidence reviews 2 and 3: prevalence. London: National Institute for Health and Care Excellence (NICE); 2020. COVID-19 rapid. Guideline: managing the long-term effects of COVID-19 (NG188. Evidence reviews 2 and 3: prevalence. London: National Institute for Health and Care Excellence (NICE); 2020.
6.
8.
go back to reference Michelen M, Manoharan L, Elkheir N et al. Characterising long COVID: a living systematic review. BMJ Glob Health, 2021; 6(9). Michelen M, Manoharan L, Elkheir N et al. Characterising long COVID: a living systematic review. BMJ Glob Health, 2021; 6(9).
9.
go back to reference Behnood SA, Shafran R, Bennett SD, et al. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: a meta-analysis of controlled and uncontrolled studies. J Infect. 2022;84(2):158–70.CrossRefPubMed Behnood SA, Shafran R, Bennett SD, et al. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: a meta-analysis of controlled and uncontrolled studies. J Infect. 2022;84(2):158–70.CrossRefPubMed
10.
go back to reference Munblit D, Sigfrid L, Warner JO. Setting priorities to address research gaps in long-term COVID-19 outcomes in children. JAMA Pediatr. 2021;175(11):1095–6.CrossRefPubMed Munblit D, Sigfrid L, Warner JO. Setting priorities to address research gaps in long-term COVID-19 outcomes in children. JAMA Pediatr. 2021;175(11):1095–6.CrossRefPubMed
11.
go back to reference Huang J, Zhao S, Chong KC, et al. Infection rate in Guangzhou after easing the zero-COVID policy: seroprevalence results to ORF8 antigen. Lancet Infect Dis. 2023;23(4):403–4.CrossRefPubMed Huang J, Zhao S, Chong KC, et al. Infection rate in Guangzhou after easing the zero-COVID policy: seroprevalence results to ORF8 antigen. Lancet Infect Dis. 2023;23(4):403–4.CrossRefPubMed
12.
go back to reference Xinhua. China focus: COVID-19 response further optimized with 10 new measures. 2022. Xinhua. China focus: COVID-19 response further optimized with 10 new measures. 2022.
13.
go back to reference WHO. TAG-VE statement on the meeting of 3 January on the COVID-19 situation in China. 2023. WHO. TAG-VE statement on the meeting of 3 January on the COVID-19 situation in China. 2023.
14.
go back to reference Choi SH, Choi JH, Lee JK, et al. Clinical characteristics and outcomes of children with SARS-CoV-2 infection during the Delta and Omicron variant-dominant periods in Korea. J Korean Med Sci. 2023;38(9):e65.CrossRefPubMedPubMedCentral Choi SH, Choi JH, Lee JK, et al. Clinical characteristics and outcomes of children with SARS-CoV-2 infection during the Delta and Omicron variant-dominant periods in Korea. J Korean Med Sci. 2023;38(9):e65.CrossRefPubMedPubMedCentral
15.
go back to reference Petersen MS, I KS, Eliasen EH, et al. Clinical characteristics of the Omicron variant - results from a nationwide symptoms Survey in the Faroe Islands. Int J Infect Dis. 2022;122:636–43.CrossRefPubMedPubMedCentral Petersen MS, I KS, Eliasen EH, et al. Clinical characteristics of the Omicron variant - results from a nationwide symptoms Survey in the Faroe Islands. Int J Infect Dis. 2022;122:636–43.CrossRefPubMedPubMedCentral
16.
go back to reference DeWitt ME, Tjaden AH, Herrington D, et al. COVID-19 symptoms by variant period in the North Carolina COVID-19 community research partnership, North Carolina, USA. Emerg Infect Dis. 2023;29(1):207–11.CrossRefPubMedPubMedCentral DeWitt ME, Tjaden AH, Herrington D, et al. COVID-19 symptoms by variant period in the North Carolina COVID-19 community research partnership, North Carolina, USA. Emerg Infect Dis. 2023;29(1):207–11.CrossRefPubMedPubMedCentral
17.
go back to reference Menni C, Valdes AM, Polidori L, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet. 2022;399(10335):1618–24.CrossRefPubMedPubMedCentral Menni C, Valdes AM, Polidori L, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet. 2022;399(10335):1618–24.CrossRefPubMedPubMedCentral
18.
go back to reference Sha J, Meng C, Sun J, et al. Clinical and upper airway characteristics of 3715 patients with the Omicron variant of SARS-Cov-2 in Changchun, China. J Infect Public Heal. 2023;16(3):422–9.CrossRef Sha J, Meng C, Sun J, et al. Clinical and upper airway characteristics of 3715 patients with the Omicron variant of SARS-Cov-2 in Changchun, China. J Infect Public Heal. 2023;16(3):422–9.CrossRef
19.
go back to reference Molteni E, Sudre CH, Canas LS, et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc. 2021;5(10):708–18.CrossRef Molteni E, Sudre CH, Canas LS, et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc. 2021;5(10):708–18.CrossRef
20.
go back to reference Butt AA, Dargham SR, Loka S et al. Coronavirus disease 2019 disease severity in children infected with the Omicron variant. Clin Infect Dis 2022 2022-08-24;75(1):e361–7. Butt AA, Dargham SR, Loka S et al. Coronavirus disease 2019 disease severity in children infected with the Omicron variant. Clin Infect Dis 2022 2022-08-24;75(1):e361–7.
21.
go back to reference Arjun MC, Singh AK, Roy P et al. Long COVID following Omicron wave in Eastern India-A retrospective cohort study. J Med Virol 2023 2023-01-01;95(1):e28214. Arjun MC, Singh AK, Roy P et al. Long COVID following Omicron wave in Eastern India-A retrospective cohort study. J Med Virol 2023 2023-01-01;95(1):e28214.
22.
go back to reference Qasmieh SA, Robertson MM, Teasdale CA et al. The prevalence of SARS-CoV-2 infection and long COVID in U.S. adults during the BA.4/BA.5 surge, June-July 2022. Prev Med 2023 2023-04-01;169:107461. Qasmieh SA, Robertson MM, Teasdale CA et al. The prevalence of SARS-CoV-2 infection and long COVID in U.S. adults during the BA.4/BA.5 surge, June-July 2022. Prev Med 2023 2023-04-01;169:107461.
23.
go back to reference Kathirvel N. Post COVID-19 pandemic mental health challenges. Asian J Psychiatr 2020 2020-10-01;53:102430. Kathirvel N. Post COVID-19 pandemic mental health challenges. Asian J Psychiatr 2020 2020-10-01;53:102430.
24.
go back to reference Peluso MJ, Deveau TM, Munter SE et al. Impact of pre-existing chronic viral infection and reactivation on the development of long COVID. medRxiv 2022 2022-07-22. Peluso MJ, Deveau TM, Munter SE et al. Impact of pre-existing chronic viral infection and reactivation on the development of long COVID. medRxiv 2022 2022-07-22.
26.
go back to reference Almeria M, Cejudo JC, Sotoca J, Deus J, Krupinski J. Cognitive profile following COVID-19 infection: clinical predictors leading to neuropsychological impairment. Brain Behav Immun Health 2020 2020-12-01;9:100163. Almeria M, Cejudo JC, Sotoca J, Deus J, Krupinski J. Cognitive profile following COVID-19 infection: clinical predictors leading to neuropsychological impairment. Brain Behav Immun Health 2020 2020-12-01;9:100163.
27.
go back to reference Mazza MG, De Lorenzo R, Conte C et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun 2020 2020-10-01;89:594–600. Mazza MG, De Lorenzo R, Conte C et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun 2020 2020-10-01;89:594–600.
28.
go back to reference Frere JJ, Serafini RA, Pryce KD et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci Transl Med 2022 2022-09-28;14(664):q3059. Frere JJ, Serafini RA, Pryce KD et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci Transl Med 2022 2022-09-28;14(664):q3059.
Metadata
Title
Acute and persistent symptoms of COVID-19 infection in school-aged children: a retrospective study from China
Authors
Honglin Wang
Fangfang Lu
Xiuxian Ni
Rijing Luo
Linxiang Chen
Jing Yuan
Zhen Zhang
Qiuying Lv
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-17822-5

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue